| Sep 16 |
Instil Bio Stock Skyrockets 641% in One Week: Here's Why
|
| Sep 16 |
Insider Buying: Summit Therapeutics Co-CEO & Executive Chairman Bought US$75m Of Shares
|
| Sep 16 |
Promising Anti-Tumor Activity and Safety of Ivonescimab in Combination Therapies in CRC, TNBC, and HNSCC Featured at ESMO 2024
|
| Sep 15 |
Chewy, Broadcom And MicroStrategy Are Among Top 10 Large Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
|
| Sep 14 |
Is Summit Therapeutics Inc. (NASDAQ:SMMT) an Unstoppable Growth Stock To Buy Now?
|
| Sep 13 |
Summit boosts Instil, BioNTech as lead drug beats Merck’s Keytruda
|
| Sep 13 |
Why Summit Therapeutics Skyrocketed 123% This Week
|
| Sep 12 |
Biotech Stock Roundup: TERN, SMMT Stocks Surge on Study Data, GSK's Vaccine Study Fails & More
|
| Sep 12 |
Why Summit Therapeutics Stock Is Soaring Again Today
|
| Sep 12 |
Summit Therapeutics, With 85% Gain This Week, Rockets Again On $235 Million Sale
|
